This study examined the effects of eradication of Helicobacter pylori (H pylon) infection on gastric mucosal morphology and acid secretion. Sixteen H pylori positive patients with enlarged gastric body folds were divided into two groups: (a) patients with moderate enlargement (fold width: 6 to 10 mm, n= 8) and (b) patients with severe enlargement (>10 mm, n=8). After successful treatment, gastric body fold width was reduced in both groups (p<001) with an associated decrease in inflammatory infiltrates in the body mucosa (p<0.01 and p<0 05).
Abstract
This study examined the effects of eradication of Helicobacter pylori (H pylon) infection on gastric mucosal morphology and acid secretion. Sixteen H pylori positive patients with enlarged gastric body folds were divided into two groups: (a) patients with moderate enlargement (fold width: 6 to 10 mm, n= 8) and (b) patients with severe enlargement (>10 mm, n=8). After successful treatment, gastric body fold width was reduced in both groups (p<001) with an associated decrease in inflammatory infiltrates in the body mucosa (p<0.01 and p<0 05).
Basal acid output and tetragastrin stimulated maximal acid output (mean (SEM)) in all 16 patients significantly increased from 1*1 (0.5) to 2*9 (0.9) mmol/h (p<005) and from 5-4 (1.3) to (2. 3) mmol/h (p<0.01), respectively, with a significant decrease in fasting serum gastrin concentrations, from 127-1 (16.1) to 59-6 (3.8) pg/ml (p<0.01). The increase in acid secretion after eradication of Hpylori was more noticeable in the severe group, who had shown lower acid secretion and higher serum gastrin concentrations (p<0.05) before eradication, than the increase seen in the moderate group. The decreases in ammonia nitrogen content seen after eradication were significant in basal (from 0-91 (0.17) to 0 37 (0.08) mmol/h, p<005) and stimulated gastric secretions (from Stolte et a16 reported that patients with fold width > 10 mm had more severe inflammation and Hpylori colonisation of the gastric body mucosa. Although H pylori infection and inflammation of the body mucosa may affect acid secretion, this association has not been clearly shown in H pylori positive patients with enlarged gastric body folds. In this study, we have investigated the effects of eradication of H pylori on gastric morphology and acid secretion in patients with H pylori positivity and enlarged gastric body folds. Additionally, we have examined changes in gastric ammonia content, which may be increased by ammonia production from urea by H pylori urease.
Methods
We identified 16 Hpyloni positive patients with enlarged gastric body folds who had successful eradication of H pylori infection. Initially, 19 H pylori positive patients with enlarged gastric body folds were enrolled in the study, but three patients failed treatment and were excluded from further study. All patients had undergone endoscopic examination after the finding of crowded, tortuous, and enlarged gastric body folds by barium study as part of a mass screening for gastric carcinoma. The barium study was performed in each patient using the same equipment and agents by experienced radiologists. The width of the gastric fold was measured on double contrast radiographs of the appropriately distended stomach in the supine position. We had known by experience and also confirmed in some patients in this study that this method of measurement of the gastric fold had good reproducibility. Gastric body folds were considered to be enlarged when the widest fold was greater than 5 mm.7 8 The mean (SEM) of the widest fold was 9.3 (0 5) mm (range 6-12 mm). Endoscopic examination in all 16 by a colorimetric method'2 (Ammonia Test Wako, Wako, Osaka, Japan). Each patient received triple therapy with bismuth subnitrate or subcarboxylate 1 g thrice daily, metronidazole 250 mg twice daily, and tetracycline hydrochloride 250 mg four times daily for three weeks. Four to 10 weeks after completion of this treatment schedule, fasting serum gastrins, endoscopic examination, and gastric secretion studies were repeated. At 7 to 29 weeks after completion of treatment, an upper gastrointestinal barium study was repeated for reassessment of the size of the folds. All results were expressed as mean (SEM). Statistical analysis was performed using the Wilcoxon signed rank test and the Mann-Whitney test. Statistical significance was assigned for any p value less than 0 05.
Results
Baseline histological examinations showed mononuclear and polymorphonuclear infiltrates in the body mucosa, as well as in the antral mucosa, in both the moderate and severe groups (Table I ). In the severe group, polymorphonuclear infiltrates in the body mucosa were significantly more severe than those in the antral mucosa (p<0.05). When the severe group was compared with the moderate group, both mononuclear and polymorphonuclear infiltrates in the body mucosa were more extensive in the severe group. Polymorphonuclear infiltrates were nearly absent in the antral and body mucosa after eradication; although the mononuclear infiltrate was significantly decreased (p<005 and p<0-01), it persisted to a mild degree. The width of gastric body folds was significantly reduced in both groups after treatment (p<0-01). In the moderate group, the fold width of two patients was reduced to less than 5 mm; in the severe group, the fold width of none of the patients was reduced to less than 5 mm.
The Figure shows the basal acid output and maximal acid output before and after eradication of H pylori in each patient. Before eradication, both basal acid output and maximal acid output were lower in the severe group compared with the moderate group, although this difference was not statistically significant (Table II) Differences in the distribution of Hpylori infection or its associated inflammation, or both may result from differences in either strains of H pylori or immune responses of the host. Moreover, our finding of comparatively severe inflammation of the body mucosa and more noticeable inhibition of acid secretion in the severe group compared with the moderate group suggests that inflammation of the body mucosa is associated with both enlargement of gastric body folds and inhibition of acid secretion in H pylori positive patients with enlarged gastric body folds.
This study has shown that fasting serum gastrin concentrations decreased after eradication of H pylori in these patients. The lower fasting serum gastrin concentrations may result from the increase in acid secretion after eradication of H pyloni. It has been reported that circulating gastrin concentrations decrease despite no evident change in acid secretion after eradication of H pylori in patients with duodenal ulcer. We have previously reported that eradication of H pylori normalises both serum gastrin concentration and antral gastrin cell number in a patient with primary gastrin cell hyperplasia characterised by hypergastrinaemia and hyperchlorhydria.5 This patient also showed an improvement in inflammatory infiltrates in the antral mucosa and unchanged acid secretion. H pylori infection and its associated inflammation of the antral mucosa has now been reported in patients with enlarged gastric body folds as well as patients with duodenal ulcer or our patient with primary gastrin cell hyperplasia. Therefore, the decrease in fasting serum gastrin concentrations after eradication may be related to not only the concomitant increase in acid secretion but also the improvement in the inflammation caused by H pylori infection in the antral mucosa.
The prevalence of enlarged gastric body folds in a barium study as part of a mass screening for gastric carcinoma in our institute has been about 15%. We believe, therefore, that enlarged fold gastritis is not an uncommon type of chronic gastritis, and must be associated with H pylori infection because of the high prevalence of H pylori infection in chronic gastritis.14 Accordingly, we think that H pylori associated enlarged fold gastritis may not be an uncommon subgroup of the population with H pylori infection, at least in Japan. The histological characterisation of H pylori associated enlarged fold gastritis, as well as the effects of eradication of Hpylori on gastric folds and acid secretion, may be useful in the differential diagnosis of enlarged gastric folds. Moreover, this study has introduced interesting questions, that is, whether or not comparatively severe chronic inflammation of the gastric body mucosa may lead to the atrophy of fundic glands, and longstanding inhibition of acid secretion may participate in gastric carcinogenesis through increasing intragastric formation of N-nitroso compounds.14
